Jemmax Nutraceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 14-12-2024
- Paid Up Capital ₹ 1.00 M
as on 14-12-2024
- Company Age 8 Year,
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2020)
- Profit 82.24%
(FY 2020)
- Ebitda 84.00%
(FY 2020)
- Net Worth -7.05%
(FY 2020)
- Total Assets -4.24%
(FY 2020)
About Jemmax Nutraceuticals
The Corporate was formerly known as Jemmax Carbons Private Limited. The Company is engaged in the Professional Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Eugine Saveri and Eugine Julietdhas serve as directors at the Company.
- CIN/LLPIN
U74110TN2016PTC113908
- Company No.
113908
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Dec 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tirunelveli, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Jemmax Nutraceuticals Private Limited offer?
Jemmax Nutraceuticals Private Limited offers a wide range of products and services, including Short Term Diploma & Course Provider, Certificate Courses.
Who are the key members and board of directors at Jemmax Nutraceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Eugine Saveri  | Director | 28-Dec-2016 | Current |
| Eugine Julietdhas | Director | 28-Dec-2016 | Current |
Financial Performance of Jemmax Nutraceuticals.
Jemmax Nutraceuticals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 82.24% increase in profit. The company's net worth dipped by a decrease of 7.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jemmax Nutraceuticals?
Unlock access to Jemmax Nutraceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Jemmax Technologies Private LimitedActive 10 years 11 monthsEugine Saveri and Eugine Julietdhas are mutual person
- Jemmax Immovables Private LimitedActive 2 years 2 months
Eugine Saveri and Eugine Julietdhas are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jemmax Nutraceuticals?
Unlock and access historical data on people associated with Jemmax Nutraceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jemmax Nutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jemmax Nutraceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
